Lockheed Martin Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.34M Sell
55,530
-3,850
-6% -$301K 0.16% 81
2025
Q1
$4.3M Sell
59,380
-1,390
-2% -$101K 0.18% 78
2024
Q4
$4.5M Buy
+60,770
New +$4.5M 0.18% 75
2023
Q4
Sell
-59,050
Closed -$4.49M 151
2023
Q3
$4.49M Sell
59,050
-83,370
-59% -$6.34M 0.34% 57
2023
Q2
$13.4M Sell
142,420
-1,350
-0.9% -$127K 0.77% 36
2023
Q1
$11.9M Buy
143,770
+116,580
+429% +$9.64M 0.67% 33
2022
Q4
$2.03M Sell
27,190
-25,620
-49% -$1.91M 0.13% 82
2022
Q3
$4.36M Buy
52,810
+19,100
+57% +$1.58M 0.35% 56
2022
Q2
$3.21M Sell
33,710
-52,116
-61% -$4.95M 0.22% 72
2022
Q1
$10.1M Buy
85,826
+25,790
+43% +$3.04M 0.56% 50
2021
Q4
$7.78M Hold
60,036
0.42% 58
2021
Q3
$6.8M Sell
60,036
-61,990
-51% -$7.02M 0.37% 50
2021
Q2
$12.6M Sell
122,026
-35,170
-22% -$3.64M 0.66% 38
2021
Q1
$13.1M Sell
157,196
-53,570
-25% -$4.48M 0.67% 43
2020
Q4
$19.2M Buy
210,766
+43,600
+26% +$3.98M 0.99% 18
2020
Q3
$13.3M Sell
167,166
-18,450
-10% -$1.47M 0.83% 28
2020
Q2
$12.8M Buy
185,616
+14,700
+9% +$1.02M 0.85% 29
2020
Q1
$10.7M Buy
170,916
+126,900
+288% +$7.98M 0.73% 31
2019
Q4
$3.42M Sell
44,016
-85,314
-66% -$6.63M 0.18% 62
2019
Q3
$9.48M Sell
129,330
-66,090
-34% -$4.84M 0.6% 29
2019
Q2
$12M Buy
195,420
+120,420
+161% +$7.41M 0.55% 50
2019
Q1
$4.78M Buy
75,000
+38,700
+107% +$2.47M 0.22% 55
2018
Q4
$1.85M Buy
36,300
+21,600
+147% +$1.1M 0.09% 55
2018
Q3
$853K Sell
14,700
-20,550
-58% -$1.19M 0.04% 58
2018
Q2
$1.71M Hold
35,250
0.08% 54
2018
Q1
$1.64M Buy
+35,250
New +$1.64M 0.07% 77
2017
Q4
Sell
-25,200
Closed -$918K 133
2017
Q3
$918K Sell
25,200
-46,500
-65% -$1.69M 0.05% 105
2017
Q2
$2.83M Buy
71,700
+33,300
+87% +$1.31M 0.16% 75
2017
Q1
$1.2M Sell
38,400
-3,600
-9% -$113K 0.07% 109
2016
Q4
$1.31M Sell
42,000
-49,200
-54% -$1.54M 0.11% 84
2016
Q3
$3.67M Hold
91,200
0.32% 44
2016
Q2
$3.03M Buy
+91,200
New +$3.03M 0.3% 52